Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 8/20 | 0.84 |
| ▸ | PGR | P06401 | 4/20 | 0.81 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.81 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.80 |
| ▸ | AR | P10275 | 3/20 | 0.73 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.72 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | SHBG | P04278 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3049344 | 1.00 | NR3C2 (0.84) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL20553192 | 0.99 | NR3C2 (0.82) | NR3C2PGRNR3C1HIF1AKMT2A | |
| Hydroxyurea SCHEMBL9938657 | 0.94 | NR3C2 (0.75) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL11293782 | 0.92 | NR3C2 (0.84) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL11584228 | 0.92 | PGR (0.72) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL11582589 | 0.92 | PGR (0.72) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL11582594 | 0.92 | PGR (0.72) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL24966579 | 0.92 | NR3C2 (0.82) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL28463036 | 0.91 | NR3C2 (0.84) | NR3C2PGRNR3C1HIF1AKMT2A | |
| SCHEMBL14936105 | 0.91 | NR3C2 (1.00) | NR3C2PGRNR3C1HIF1AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2644 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3243835-B1 | ALBUMIN VARIANTS AND CONJUGATES | ALBUMEDIX LTD (GB) | 2024-04-10 | — | — | EP | claimed |
| US-11952353-B2 | STAT3 transcription factor inhibitors and methods of using the same | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2024-04-09 | — | — | US | claimed |
| EP-3337816-B1 | ALBUMIN VARIANTS AND CONJUGATES | ALBUMEDIX LTD (GB) | 2024-02-14 | — | — | EP | claimed |
| US-20230173295-A1 | Systems, Devices, and Methods for Gamma Entrainment using Sensory Stimuli to Alleviate Cognitive Deficits and/or Neuroinflammation Induced by Chemotherapy Agents | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-08 | — | — | US | claimed |
| WO-2023055904-A1 | KRAS ANTAGONISTS | TRUETIVA, Inc. (US) | 2023-04-06 | — | — | WO | claimed |
| US-20220117990-A1 | KRAS ANTAGONISTS | TRUETIVA, Inc. (US) | 2022-04-21 | — | — | US | claimed |
| US-20220017476-A1 | STAT3 TRANSCRIPTION FACTOR INHIBITORS AND METHODS OF USING THE SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2022-01-20 | — | — | US | claimed |
| US-20220008334-A1 | GASTRIC RETENTIVE DEVICES | CLEXIO BIOSCIENCES LTD. (IL) | 2022-01-13 | — | — | US | claimed |
| WO-2021216957-A1 | SYSTEMS, DEVICES, AND METHODS FOR GAMMA ENTRAINMENT USING SENSORY STIMULI TO ALLEVIATE COGNITIVE DEFICITS AND/OR NEUROINFLAMMATION INDUCED BY CHEMOTHERAPY AGENTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-10-28 | — | — | WO | claimed |
| US-11147766-B2 | Gastric retentive devices | CLEXIO BIOSCIENCES LTD. (IL) | 2021-10-19 | — | — | US | claimed |
| US-20020192273-A1 | Therapeutic patch useful for the treatment of hemorrhoids | LEC TEC CORPORATION | 2002-12-19 | — | — | US | claimed |
| US-20020188196-A1 | Cavity-filling biopsy site markers | SENORX, INC. | 2002-12-12 | — | — | US | claimed |
| JP-2002533379-A | — | — | 2002-10-08 | — | — | JP | claimed |
| US-20020064524-A1 | Formulation for topical non-invasive application in vivo | IDEA AG (DE) | 2002-05-30 | — | — | US | claimed |
| EP-1140021-A1 | IMPROVED FORMULATION FOR TOPICAL NON-INVASIVE APPLICATION IN VIVO | IDEA AG (DE) | 2001-10-10 | — | — | EP | claimed |
| WO-2000038653-A1 | IMPROVED FORMULATION FOR TOPICAL NON-INVASIVE APPLICATION IN VIVO | IDEA AG. (DE) | 2000-07-06 | — | — | WO | claimed |
| EP-1003842-A1 | CATALYTIC MONOCLONAL ANTIBODIES FOR THE IN VIVO TRANSFORMATION OF CORTICOSTEROID PRODRUGS | Abiogen Pharma S.p.A. (IT) | 2000-05-31 | — | — | EP | claimed |
| WO-1999006536-A1 | CATALYTIC MONOCLONAL ANTIBODIES FOR THE IN VIVO TRANSFORMATION OF CORTICOSTEROID PRODRUGS | ABIOGEN PHARMA S.P.A. (IT) | 1999-02-11 | — | — | WO | claimed |
| US-5219877-A | Fungicide. antiinflammatory agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-06-15 | — | — | US | claimed |
| US-5023088-A | Drug delivery dispenser | ALZA CORPORATION (US) | 1991-06-11 | — | — | US | claimed |